Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,536 | -6,985 | -3,299 | -7,022 | -3,870 |
| Depreciation Amortization | 10 | 6 | 3 | 5 | 3 |
| Accounts receivable | -460 | -311 | -402 | -245 | -318 |
| Accounts payable and accrued liabilities | -518 | -544 | -541 | 2,149 | 944 |
| Other Working Capital | -951 | -825 | -932 | 1,900 | 621 |
| Other Operating Activity | 2,850 | 2,219 | 1,616 | -1,196 | -321 |
| Operating Cash Flow | $-9,605 | $-6,440 | $-3,555 | $-4,409 | $-2,941 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,000 | 5,000 | N/A | -22,000 | N/A |
| PPE Investments | -31 | -21 | -17 | -63 | -56 |
| Investing Cash Flow | $3,969 | $4,979 | $-17 | $-22,063 | $-56 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 36,785 | 36,855 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $36,785 | $36,855 |
| Beginning Cash Position | 10,583 | 10,583 | 10,583 | 270 | 270 |
| End Cash Position | 4,947 | 9,122 | 7,011 | 10,583 | 34,128 |
| Net Cash Flow | $-5,636 | $-1,461 | $-3,572 | $10,313 | $33,858 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,605 | -6,440 | -3,555 | -4,409 | -2,941 |
| Capital Expenditure | -31 | -21 | -17 | -63 | -56 |
| Free Cash Flow | -9,636 | -6,461 | -3,572 | -4,472 | -2,997 |